Robert I. Blum - Mar 6, 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role: President & CEO, Director
Signature: /s/ John Faurescu, attorney-in-fact for Mr. Blum
Stock symbol: CYTK
Transactions as of: Mar 6, 2023
Transactions value $: $0
Form type: 4
Date filed: 3/7/2023, 03:11 PM
Previous filing: Mar 3, 2023
Next filing: Mar 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTK	Common Stock	Award	$0	+82.5K	+23.01%	$0.00	441K	Mar 6, 2023	Direct	F1
holding	CYTK	Common Stock						2.08K	Mar 6, 2023	by Trust 1	F2
holding	CYTK	Common Stock						2.08K	Mar 6, 2023	by Trust 2	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYTK	Incentive Stock Option (Right to Buy)	Award	$0	+2.56K		$0.00	2.56K	Mar 6, 2023	Common Stock	2.56K	$39.13	Direct	F4
transaction	CYTK	Non-Qualified Stock Option (Right to Buy)	Award	$0	+162K		$0.00	162K	Mar 6, 2023	Common Stock	162K	$39.13	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an addiitional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.
F2	Shares held by The Bridget Blum 2003 Irrevocable Trust.
F3	Shares held by The Brittany Blum 2003 Irrevocable Trust.
F4	This option shall vest and become exercisable over 4-years, with vesting divided into equal monthly installments commencing on April 6, 2023 and the final monthly installment vesting on April 6, 2027.